BDBM324906 9-(((1r,4r)-4-(3,5-::US10189841, Compound I-112::US10399980, Compound I-112

SMILES: CC(C)c1ccccc1-c1ncc2n(C)c(=O)n(C[C@H]3CC[C@@H](CC3)n3nc(C)cc3C)c2n1

InChI Key: InChIKey=MMHUIFSIEYJFON-MEMLXQNLSA-N

Data: 2 IC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 324906   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Ubiquitin carboxyl-terminal hydrolase 1 (Homo sapiens (Human))	BDBM324906 (9-(((1r,4r)-4-(3,5- | US10189841, Compound I-112 |...) Show SMILES CC(C)c1ccccc1-c1ncc2n(C)c(=O)n(C[C@H]3CC[C@@H](CC3)n3nc(C)cc3C)c2n1 |r,wU:22.26,wD:19.19,(-8.63,3.74,;-7.3,2.97,;-5.97,3.74,;-7.3,1.43,;-8.63,.66,;-8.63,-.88,;-7.3,-1.65,;-5.97,-.88,;-5.97,.66,;-4.63,1.43,;-4.63,2.97,;-3.3,3.74,;-1.97,2.97,;-.5,3.44,;-.1,4.93,;.4,2.2,;1.94,2.2,;-.5,.95,;-.1,-.54,;1.39,-.94,;1.78,-2.42,;3.27,-2.82,;4.36,-1.73,;3.96,-.25,;2.47,.15,;5.85,-2.13,;6.32,-3.6,;7.86,-3.6,;8.63,-4.93,;8.34,-2.13,;7.09,-1.23,;7.09,.31,;-1.97,1.43,;-3.3,.66,)| Show InChI InChI=1S/C27H34N6O/c1-17(2)22-8-6-7-9-23(22)25-28-15-24-26(29-25)32(27(34)31(24)5)16-20-10-12-21(13-11-20)33-19(4)14-18(3)30-33/h6-9,14-15,17,20-21H,10-13,16H2,1-5H3/t20-,21-	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	>2.00E+3	n/a	n/a	n/a	n/a	n/a	n/a
FORMA Therapeutics, Inc. US Patent					Assay Description The HTS assay was performed in a final volume of 20 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (1M Tris-HCl, pH 8.0 solution; Corning...				US Patent US10399980 (2019) BindingDB Entry DOI: 10.7270/Q23J3GCX
					More data for this Ligand-Target Pair
Ubiquitin carboxyl-terminal hydrolase 1 (Homo sapiens (Human))	BDBM324906 (9-(((1r,4r)-4-(3,5- | US10189841, Compound I-112 |...) Show SMILES CC(C)c1ccccc1-c1ncc2n(C)c(=O)n(C[C@H]3CC[C@@H](CC3)n3nc(C)cc3C)c2n1 |r,wU:22.26,wD:19.19,(-8.63,3.74,;-7.3,2.97,;-5.97,3.74,;-7.3,1.43,;-8.63,.66,;-8.63,-.88,;-7.3,-1.65,;-5.97,-.88,;-5.97,.66,;-4.63,1.43,;-4.63,2.97,;-3.3,3.74,;-1.97,2.97,;-.5,3.44,;-.1,4.93,;.4,2.2,;1.94,2.2,;-.5,.95,;-.1,-.54,;1.39,-.94,;1.78,-2.42,;3.27,-2.82,;4.36,-1.73,;3.96,-.25,;2.47,.15,;5.85,-2.13,;6.32,-3.6,;7.86,-3.6,;8.63,-4.93,;8.34,-2.13,;7.09,-1.23,;7.09,.31,;-1.97,1.43,;-3.3,.66,)| Show InChI InChI=1S/C27H34N6O/c1-17(2)22-8-6-7-9-23(22)25-28-15-24-26(29-25)32(27(34)31(24)5)16-20-10-12-21(13-11-20)33-19(4)14-18(3)30-33/h6-9,14-15,17,20-21H,10-13,16H2,1-5H3/t20-,21-	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<0.00200	n/a	n/a	n/a	n/a	n/a	n/a
FORMA Therapeutics, Inc. US Patent					Assay Description The HTS assay was performed in a final volume of 20 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (1M Tris-HCl, pH 8.0 solution; Corning...				US Patent US10189841 (2019) BindingDB Entry DOI: 10.7270/Q22R3TRR
					More data for this Ligand-Target Pair